SHCBP1
From Wikipedia, the free encyclopedia
SHC SH2-domain binding protein 1
|
||||||||
Identifiers | ||||||||
Symbol(s) | SHCBP1; FLJ22009; MGC26900 | |||||||
External IDs | MGI: 1338802 HomoloGene: 32123 | |||||||
|
||||||||
RNA expression pattern | ||||||||
Orthologs | ||||||||
Human | Mouse | |||||||
Entrez | 79801 | 20419 | ||||||
Ensembl | ENSG00000171241 | ENSMUSG00000022322 | ||||||
Uniprot | Q8NEM2 | Q9Z179 | ||||||
Refseq | NM_024745 (mRNA) NP_079021 (protein) |
NM_011369 (mRNA) NP_035499 (protein) |
||||||
Location | Chr 16: 45.17 - 45.21 Mb | Chr 8: 4.74 - 4.78 Mb | ||||||
Pubmed search | [1] | [2] |
SHC SH2-domain binding protein 1, also known as SHCBP1, is a human gene.[1]
[edit] References
[edit] Further reading
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171-4. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149-56. PMID 9373149.
- Schmandt R, Liu SK, McGlade CJ (1999). "Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells.". Oncogene 18 (10): 1867-79. doi: . PMID 10086341.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi: . PMID 14702039.
- Obuse C, Yang H, Nozaki N, et al. (2004). "Proteomics analysis of the centromere complex from HeLa interphase cells: UV-damaged DNA binding protein 1 (DDB-1) is a component of the CEN-complex, while BMI-1 is transiently co-localized with the centromeric region in interphase.". Genes Cells 9 (2): 105-20. PMID 15009096.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins.". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130-5. doi: . PMID 15302935.
- Jin J, Smith FD, Stark C, et al. (2004). "Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.". Curr. Biol. 14 (16): 1436-50. doi: . PMID 15324660.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi: . PMID 15489334.
- Benzinger A, Muster N, Koch HB, et al. (2005). "Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.". Mol. Cell Proteomics 4 (6): 785-95. doi: . PMID 15778465.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173-8. doi: . PMID 16189514.
- Beausoleil SA, Villén J, Gerber SA, et al. (2006). "A probability-based approach for high-throughput protein phosphorylation analysis and site localization.". Nat. Biotechnol. 24 (10): 1285-92. doi: . PMID 16964243.
- Ewing RM, Chu P, Elisma F, et al. (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry.". Mol. Syst. Biol. 3: 89. doi: . PMID 17353931.